Donate

ICYMI: October 20, 2017

October 20, 2017

ICYMI: October 20, 2017

Feature Story

F.D.A. Approves Second Gene-Altering Treatment for Cancer
WEDNESDAY, October 18, 2017 (The New York Times) — The Food and Drug Administration on Wednesday approved the second in a radically new class of treatments that genetically reboot a patient’s own immune cells to kill cancer.

The new therapy, Yescarta, made by Kite Pharma, was approved for adults with aggressive forms of a blood cancer, non-Hodgkin’s lymphoma, who have undergone two regimens of chemotherapy that failed.

You might have also missed…

Another last-ditch effort to tackle Obamacare stalls within hours of its release
Oct. 17, The Washington Post

Relationship between sugar and cancer is now clearer, scientists say
Oct. 18, USA Today

A Silent Epidemic of Cancer Is Spreading Among Men
Oct. 18, NBC News

AI used to detect breast cancer risk
Oct. 17, BBC News

Join now to keep up with the latest in cancer prevention and early detection